WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 47'8701 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 35'2041 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 127'250  127'319  127'353  127'353  127'319  125'715  122'249  115'912 
Births 1'071  1'080  1'088  1'095  1'101  1'155  1'280  1'605 
Surviving infants 1'069  1'077  1'085  1'092  1'098  1'151  1'274  1'593 
Pop. less than 5 years 5'389  5'393  5'393  5'425  5'459  5'858  6'430  8'425 
Pop. less than 15 years 16'717  16'828  16'921  17'054  17'169  18'385  22'389  27'311 
Female 15-49 years 26'731  26'902  27'057  27'264  27'460  29'155  31'194  30'403 

Number of reported case

(Click for retrospective incidence data for Japan)
Diphtheria 66 
Japanese encephalitis
Measles 228  434  450  741  11'015  22'497  3'259  13'219 
Mumps 71'549  137'060  179'635  104'568  65'361  132'659 
Pertussis 4'087  4'395  5'406  5'208  6'753  3'787  583  5'033 
Polio*
Rubella 2'353  369  89  148  303  3'120 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 116  111  104  113  123  90  47  50 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Japan)
Vaccine year result method % card seen                                                
BCG          95  94  99  94  90  96  85 
DTP1          99*  99*  99*  99*  99*  100 
DTP3          99*  99*  99*  99*  98  85  87  60 
HepB_BD         
HepB3         
Hib3         
JapEnc          99*  61  22  21 
MCV          96  94  94  94  97  96  66  69 
MCV2          92  92  97  92  78 
PCV1         
PCV3         
Pol3          99  96  98  100  95  99  90 
Rota1         
Rota_last         
Rubella1          96  94  94  94  99* 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Japan)
BCG 95  94  99  94  90  85 
DTP1 99  99  99  99  99  88  96  82 
DTP3 98  98  98  98  98  85  90  60 
HepB3
Hib3
MCV 96  94  94  94  95  96  73  69 
PCV3
Pol3 99  96  98  99  98  98  90 
Rota_last

Number of districts in the country 1'742  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 year; Yes
DT 11 years; Yes
DTaPIPV 3, 4.5, 6, 18 months; Yes
HIB 2, 3, 4 months; 1 year;
HPV 13 years (x3);
Influenza >=65 years; Yes
JapEnc 36, 37 months; 4, 9 years; Yes
MR 1, 5 years; Yes
Pneumo_conj 2, 3, 4 months; 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  No   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 1'742  1'725  1'724     
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%              

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.